EMA starts rolling review for Sputnik V va...EMAs human medicines committee has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russias Gamaleya National Centre of Epidemiology and Microbiology. more ➔
CAC builds biofuel plant for OMVChemieanlagenbau Chemnitz (CAC) is realizing one of the first large-scale plants in Europe to use innovative co-processing to produce carbon-neutral fuels. more ➔
French biotech investors launch spin-out a...Kurma Parnters and Francee investment bank have launched a €50m project named Argobio that is aimed at identifiying the most genious biotech ideas and spin out companies. more ➔
Oxular Ltd raises US$37mBritish Oxular Ltd has raised $37m in a financing round led by Forbion Parners and co-financed by IP Group, NeoMed, and V-Bio Ventures to push its pipeline. more ➔
EU life science PPPs face less budget in H...The European Commission is set to fund ten "European Partnerships" partnered with different industries with €10bn. more ➔
MosaMeat BV closes US$85m Series B financi...Cultured meat producer MosaMeat BV has announced the third and final closing of its Series B round raising US$85m. more ➔
Biomarker identifies high-risk COVID-19 pa...Austrian researchers have found that a lack of activation of the NK receptor is highly associated with severe COVID-19 disease courses. more ➔
MaxiVAX and Minaris Regenerative Medicine... Swiss cancer vaccine specialist MaxiVAX SA has hired Minaris Regenerative Medicine GmbH to produce its cell therapy MVX-ONCO-2. more ➔
EU orders additional COVID-19 vaccine dos...Pfizer Inc. and BioNTech SE have signed an agreement with the European Commission (EC) to supply an additional 200 million doses of BNT162b2 to the EU. more ➔
Novel strategy targets chronic liver disea...A resesarch team headed by HepaRegeneriX Board Member Lars Zender has presented a new approach to treat hepatocellular carcinoma (HCC) by disturbing the lipid metabolism of tumour cells. more ➔
